Jodi Wheelock in Newburgh, Indiana

Home Indiana Newburgh

Jodi Wheelock has Nurse Practitioner as her primary medical specialty. Their primary office is: 4219 Gateway Blvd in Newburgh, Indiana.

They're a part of the: Deaconess Clinic Inc medical group which has around 333 members. You can call their office at 812-426-9545 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2014 (around 10 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jodi A Wheelock Office Phone and Directions

Jodi Wheelock
Deaconess Clinic Inc
4219 Gateway Blvd
Newburgh, Indiana 47630
812-426-9545

Patient Ratings
Please rate your experience with Jodi Wheelock below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 812-426-9545

Enter a starting address:

Healthcare Info for Jodi Wheelock

Medical School: Sorry, her university is not listed
Graduation Year: 2014
The Primary Medical Specialty for Jodi Wheelock is listed as: Nurse Practitioner
Approximate Years of Experience: 10
PAC (PECOS ID)#: 2062634074
NPI #: 1891103024
NPI Created On: 07/31/2014
NPI Last Updated Listed as: 12/03/2018
Primary Taxonomy Code: 363L00000X
License Number:
71005078A
Listed Gender: Female

Accepted forms of Insurance

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Medicare

They are listed as accepting new patients.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795892441

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31